Search Press releases Keywords From To 5 Feb 2015 UCB advances Neupro® (rotigotine transdermal patch) in China: positive Phase 3 program in patients with Parkinson’s disease Read More 21 Jan 2015 UCB announces US and EU regulatory filings for the investigational antiepileptic drug brivaracetam Read More 16 Jan 2015 Neuropore and UCB enter into world-wide collaboration and agreement Read More 13 Jan 2015 UCB’s new CEO Jean-Christophe Tellier introduces executive team Read More 9 Jan 2015 Update of transparency notification UCB SA/NV Read More 8 Jan 2015 Dermira and UCB announce start of Phase 3 program for CIMZIA® (certolizumab pegol) in psoriasis Read More Pagination First page Previous page Previous … Page 99 Page 100 Page 101 Page 102 Current page 103 Page 104 Page 105 Page 106 Page 107 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
